Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Amrubicin & Lung Cancer

Amrubicin & Lung Cancer Newsletter

Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases 13 Dec 2022 23:43 GMT
… lung cancer is classified as small cell lung cancer (SCLC) or non–small cell lung cancer … from small cell lung cancer: consequences of changing … III study comparing amrubicin plus cisplatin with irinotecan … in small-cell lung cancer. Clin Lung Cancer. 2008;9(1 …
Bristol-Myers Squibb Announces Phase 3 CheckMate -331 Study Does Not Meet Primary Endpoint of Overall Survival with Opdivo Versus Chemotherapy in Patients with Previously Treated Relapsed Small Cell Lung Cancer 12 Oct 2018 12:23 GMT
… amrubicin (where approved), in patients with small cell lung cancer … with relapsed small cell lung cancer (SCLC) following … About Small Cell Lung Cancer Lung cancer is the leading cause … lung cancer and accounts for about 10% to 15% of all lung cancers …
G1 Therapeutics: An Excellent Opportunity In A Underserved Space 26 Sep 2019 17:47 GMT
… in patients with Small Cell Lung Cancer (SCLC). Drugs intended for … for myelopreservation in small cell lung cancer (SCLC). These submissions will … 's (NASDAQ:CELG) Amrubicin, Merck's (NYSE:MRK … treatment of small cell lung cancer. This tells us that …
Bristol─Myers Squibb's phase 3 CheckMate─331 study does not meet primary endpont 15 Oct 2018 13:43 GMT
… or amrubicin (where approved), in patients with small cell lung cancer ( … SCLC, non-small cell lung cancer and malignant pleural mesothelioma. … with relapsed small cell lung cancer (SCLC) following platinum- … per cent of all lung cancers. SCLC is an aggressive …
Bristol-Myers Says Phase 3 CheckMate -331 Study Fails To Meet Primary Endpoint 12 Oct 2018 11:35 GMT
… or amrubicin (where approved), in patients with small cell lung cancer or SCLC … , including SCLC, non-small cell lung cancer and malignant pleural mesothelioma. As …
CytRx: SCLC Study Still Breathing? 13 Jul 2017 19:44 GMT
… battle against lung cancer and … lung cancers (NSCLC) represent most lung cancers, with only approximately 15% of lung cancers … being small cell lung cancer … topotecan, and amrubicin are potential second …
BUYINS.NET: IPK, STNG, PLOW, CELGZ Are Seasonally Ripe To Go Up In the Next Five Weeks 30 Jan 2017 14:08 GMT
… Amrubicin, a Phase III clinical trial product for small cell lung cancer treatment …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS